SCHEMBL652803

SCHEMBL652803

CC(C)(C)OC(=O)N1C[C@@H]2CCN(C(=O)OCc3ccccc3)C[C@@H]21

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 1/20 0.53
JAK1 P23458 1/20 0.53
SMN1; SMN2 Q16637 3/20 0.52
NPC1 O15118 2/20 0.52
RAB9A P51151 2/20 0.52
HTT P42858 1/20 0.51
PARP1 P09874 1/20 0.51
CYP2C19 P33261 1/20 0.50
GPR119 Q8TDV5 3/20 0.49
XIAP P98170 1/20 0.47
BIRC2 Q13490 1/20 0.47
AGTR2 P50052 1/20 0.47
PDE4B Q07343 1/20 0.46
CYP2D6 P10635 2/20 0.45
CYP2C9 P11712 2/20 0.45
GRIN2B Q13224 2/20 0.45
CYP3A4 P08684 1/20 0.45
PDK1 Q15118 1/20 0.45
PDK2 Q15119 1/20 0.45
PDK3 Q15120 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1586077 0.96 JAK2 (0.55) JAK2JAK1SMN1; SMN2NPC1RAB9A
SCHEMBL1586076 0.96 JAK2 (0.55) JAK2JAK1SMN1; SMN2NPC1RAB9A
SCHEMBL30923126 0.94 JAK2 (0.53) JAK2JAK1SMN1; SMN2NPC1RAB9A
SCHEMBL18452966 0.94 JAK2 (0.53) JAK2JAK1SMN1; SMN2NPC1RAB9A
SCHEMBL3058464 0.91 CCR5 (0.51) JAK2JAK1SMN1; SMN2NPC1RAB9A
SCHEMBL31288285 0.90 JAK2 (0.54) JAK2JAK1SMN1; SMN2NPC1RAB9A
SCHEMBL1991997 0.90 JAK2 (0.54) JAK2JAK1SMN1; SMN2NPC1RAB9A
SCHEMBL7689008 0.90 PARP1 (0.49) JAK2JAK1SMN1; SMN2NPC1RAB9A
SCHEMBL652371 0.90 PARP1 (0.49) JAK2JAK1SMN1; SMN2NPC1RAB9A
SCHEMBL8569488 0.87 CCR5 (0.53) JAK2JAK1SMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119635-B2 Diazabicyclic central nervous system active agents ABBOTT LABORATORIES (US) 2012-02-21 US disclosed
EP-2298775-A1 Diazabicyclic central nervous system active agents Abbott Laboratories (US) 2011-03-23 EP disclosed
EP-2295437-A1 Diazabicyclic central nervous system active agents Abbott Laboratories (US) 2011-03-16 EP disclosed